［1］ BOCCALETTO P,MACHNICKA MA,PURTA E,et al.MODOMICS:a database of RNA modification pathways.2017 update［J］.Nucleic Acids Research，2018，46(D1):D303-D307.
［2］ LIU J,YUE Y,HAN D,et al.A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation［J］.Nature Chemical Biology，2014，10(2):93-95.
［3］ PING XL,SUN BF,WANG L,et al.Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase［J］.Cell Research，2014，24(2):177-189.
［4］ CHOE J,LIN S,ZHANG W,et al.mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis［J］.Nature，2018，561(7724):556-560.
［5］ JIA G,FU Y,ZHAO X,et al.N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO［J］.Nature Chemical Biology,2011，7(12):885-887.
［6］ ZHENG G,DAHL JA,NIU Y,et al.ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility［J］.Molecular Cell，2013，49(1):18-29.
［7］ ALARCON CR,GOODARZI H,LEE H,et al.HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events［J］.Cell，2015，162(6):1299-1308.
［8］ ROUNDTREE IA,LUO GZ,ZHANG Z,et al.YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs［J］.Elife，2017，6:e31311.
［9］ DU H,ZHAO Y,HE J,et al.YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex［J］.Nature Communication，2016，7:12626.
［10］ SHI H,WANG X,LU Z,et al.YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA［J］.Cell Research，2017，27(3):315-328.
［11］ MEYER KD,PATIL DP,ZHOU J,et al.5' UTR m(6)A promotes cap-independent translation［J］.Cell，2015，163(4):999-1010.
［12］ TREWICK SC,HENSHAW TF,HAUSINGER RP,et al.Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage［J］.Nature，2002，419(6903):174-178.
［13］ GERKEN T,GIRARD CA,TUNG YC,et al.The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase［J］.Science，2007，318(5855):1469-1472.
［14］ WEI J,LIU F,LU Z,et al.Differential m6A,m6Am,and m1A demethylation mediated by FTO in the cell nucleus and cytoplasm［J］.Molecular Cell，2018，71(6):973-985.e5.
［15］ JIA G,YANG CG,YANG S,et al.Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO［J］.FEBS Letters，2008，582(23-24):3313-3319.
［16］ ZHENG G,DAHL JA,NIU Y,et al.ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility［J］.Molecular Cell，2013，49(1):18-29.
［17］ FU Y,DOMINISSINI D,RECHAVI G,et al.Gene expression regulation mediated through reversible m6A RNA methylation［J］.Nature Reviews Genetics，2014，15(5):293-306.
［18］ FENG C,LIU Y,WANG G,et al.Crystal structures of the human RNA demethylase ALKBH5 reveal basis for substrate recognition［J］.Journal of Biological Chemistry，2014，289(17):11571-11583.
［19］ AIK W,SCOTTI JS,CHOI H,et al.Structure of human RNA N6-methyladenine demethylase ALKBH5 provides insights into its mechanisms of nucleic acid recognition and demethylation［J］.Nucleic Acids Research，2014，42(7):4741-4754.
［20］ XU C,LIU K,TEMPEL W,et al.Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation［J］.Journal of Biological Chemistry，2014，289(25):17299-17311.
［21］ WU L,WU D,NING J,et al.Changes of N6-methyladenosine modulators promote breast cancer progression［J］.BMC Cancer，2019，19(1):326.
［22］ ZHANG C,SAMANTA D,LU H,et al.Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA［J］.Proceedings of the National Academy of Sciences of the United States of America，2016，113(14):E2047-2056.
［23］ ZHANG C,ZHI WI,LU H,et al.Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217-and ALKBH5-mediated modulation of RNA methylation in breast cancer cells［J］.Oncotarget，2016，7(40):64527-64542.
［24］ LIU H,LYU H,JIANG G,et al.ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer［J］.Cancer Research，2022，82(21):3974-3986.
［25］ LIU Z,CHEN Y,WANG L,et al.ALKBH5 promotes the proliferation of glioma cells via enhancing the mRNA stability of G6PD［J］.Neurochemical Research，2021，46(11):3003-3011.
［26］ CUI Y,WANG Q,LIN J,et al.miRNA-193a-3p regulates the AKT2 pathway to inhibit the growth and promote the apoptosis of glioma cells by targeting ALKBH5［J］.Frontiers in Oncology，2021，11:600451.
［27］ LIU B,ZHOU J,WANG C,et al.LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma［J］.Cell Death Disease，2020，11(5):384.
［28］ LI L,YANG M,PU X,et al.ALKBH5-PYCR2 positive feedback loop promotes proneural-mesenchymal transition via proline synthesis in GBM［J］.Journal of Cancer，2023，14(9):1579-1591.
［29］ TANG W,XU N,ZHOU J,et al.ALKBH5 promotes PD-L1-mediated immune escape through m6A modification of ZDHHC3 in glioma［J］.Cell Death Discovery，2022，8(1):497.
［30］ CHANG G,XIE GS,MA L,et al.USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5［J］.Neuro Oncology，2023，25(5):841-853.
［31］ TSUCHIYA K,YOSHIMURA K,IWASHITA Y,et al.m6A demethylase ALKBH5 promotes tumor cell proliferation by destabilizing IGF2BPs target genes and worsens the prognosis of patients with non-small-cell lung cancer［J］.Cancer Gene Therapy，2022，29(10):1355-1372.
［32］ GUO J,WU Y,DU J,et al.Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression［J］.Oncogenesis，2018，7(6):49.
［33］ ZHANG D,NING J,OKON I,et al.Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer［J］.Cell Death Disease，2021，12(6):518.
［34］ CHAO Y,SHANG J,JI W.ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia［J］.Biochemical and Biophysical Research Communications，2020，521(2):499-506.
［35］ YU H,ZHANG Z.ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma［J］.Mamm Genome,2021，32(3):195-203.
［36］ SHEN W,PU J,ZUO Z,et al.The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the lncRNA PVT1［J］.Cancer Cell International，2022，22(1):353.
［37］ ZHU H,GAN X,JIANG X,et al.ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2［J］.Journal of Cancer Research and Clinical Oncology，2019，38(1):163.
［38］ JIANG Y,WAN Y,GONG M,et al.RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway［J］.Journal of Cellular and Molecular Medicine，2020，24(11):6137-6148.
［39］ NIE S,ZHANG L,LIU J,et al.ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer［J］.Journal of Experimental & Clinical Cancer Research， 2021，40(1):284.
［40］ SUN R,YUAN L,JIANG Y,et al.ALKBH5 activates FAK signaling through m6A demethylation in ITGB1 mRNA and enhances tumor-associated lymphangiogenesis and lymph node metastasis in ovarian cancer［J］.Theranostics，2023，13(2):833-848.
［41］ WANG J,LI Y,WANG P,et al.Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis［J］.Cell Stem Cell，2020，27(1):81-97.e8.
［42］ LI R,WU X,XUE K,et al.RNA demethylase ALKBH5 promotes tumorigenesis of t(8;21) acute myeloid leukemia via ITPA m6A modification［J］.Biomark Reseaser，2023，11(1):30.
［43］ WANG P,WANG J,YAO S,et al.Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival［J］.Journal of Biological Chemistry，2023，299(8):105055.
［44］ ZANG J,GUO S,PIAO HY,et al.ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1［J］.Journal of Physiologyand Biochemistry，2019，75(3):379-389.
［45］ CHEN C,ZHAI E,LIU Y,et al.ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer［J］.Cancer Cell International，2023，23(1):293.
［46］ FANG Y,WU X,GU Y,et al.LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6A-YTHDF2-dependent manner［J］.Clinical and Translational Medicine，2023，13(3):e1205.
［47］ WANG S,WANG Y,ZHANG Z,et al.Long non-coding RNA NRON promotes tumor proliferation by regulating ALKBH5 and Nanog in gastric cancer［J］.Journal of Cancer，2021，12(22):6861-6872.
［48］ GUO T,LIU DF,PENG SH,et al.ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1［J］.American Journal of Translational Research，2020，12(8):4542-4549.
［49］ SHEN D,LIN J,XIE Y,et al.RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner［J］.Clinical and Translational Medicine，2023，13(5):e1279.
［50］ YU H,YANG X,TANG J,et al.ALKBH5 inhibited cell proliferation and sensitized bladder cancer cells to cisplatin by m6A-CK2α-mediated glycolysis［J］.Molecular Therapy-Nucleic Acids，2020，23:27-41.
［51］ HE Y,HU H,WANG Y,et al.ALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylation［J］.Cellular Physiology and Biochemistry，2018，48(2):838-846.
［52］ GUO X,LI K,JIANG W,et al.RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner［J］.Molecular Cancer，2020，19(1):91.
［53］ TANG B,YANG Y,KANG M,et al.m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling［J］.Molecular Cancer，2020，19(1):3.
［54］ HUANG R,YANG L,ZHANG Z,et al.RNA m6A demethylase ALKBH5 protects against pancreatic ductal adenocarcinoma via targeting regulators of iron metabolism［J］.Frontiers in Cell and Developmental Biology，2021，9:724282.
［55］ JIN D,GUO J,WU Y,et al.m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC［J］.Molecular Cancer，2020，19(1):40.
［56］ SUN Z,SU Z,ZHOU Z,et al.RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer［J］.FASEB Journal，2022，36(5):e22283.
［57］ ZHANG S,ZHAO BS,ZHOU A,et al.m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program［J］.Cancer Cell，2017，31(4):591-606.e6.
［58］ SHRIWAS O,PRIYADARSHINI M,SAMAL SK,et al.DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG［J］.Apoptosis，2020，25(3-4):233-246.
［59］ FUKUMOTO T,ZHU H,NACARELLI T,et al.N6-methylation of adenosine of FZD10 mRNA contributes to PARP inhibitor resistance［J］.Cancer Research，2019，79(11):2812-2820.
［60］ SELBEG S,SELI N,KANKURI E,et al.Rational design of novel anticancer small-molecule RNA m6A demethylase ALKBH5 inhibitors［J］.ACS Omega，2021，6(20):13310-13320.
［61］ MALACRIDA A,RIVARA M,DI DA,et al.3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line［J］.Bioorganic & Medicinal Chemistry，2020，28(4):115300.
［62］ LI N,KANG Y,WANG L,et al.ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment［J］.Proceedings of the National Academy of Sciences of the United States of America，2020，117(33):20159-20170.
［63］ PURSLOW JA,NGUYEN TT,KHATIWADA B,et al.N6-methyladenosine binding induces a metal-centered rearrangement that activates the human RNA demethylase ALKBH5［J］.Science Advances，2021，7(34):eabi8215.
［64］ XIE LJ,YANG XT,WANG RL,et al.Identification of flavin mononucleotide as a cell-active artificial N6-methyladenosine RNA demethylase［J］.Angewandte Chemie International Edition，2019，58(15):5028-5032.
［65］ KHAN S,HE Y,ZHANG X,et al.PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics［J］.Oncogene，2020，39(26):4909-4924.